Blueprint Investment Partners LLC Novo Nordisk A S Transaction History

Blueprint Investment Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $35,202 - $42,331	-266 Reduced 6.85%	3,619 $575,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $249,606 - $329,393	2,434 Added 167.75%	3,885 $525,000
Q3 2022 Nov 09, 2022	BUY	$95.28 - $116.93 $138,251 - $169,665	1,451 New	1,451 $145,000
Q2 2022 Aug 09, 2022	SELL	$103.24 - $121.81 $204,311 - $241,061	-1,979 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $70,849 - $85,642	-761 Reduced 27.77%	1,979 $220,000
Q4 2021 Feb 15, 2022	BUY	$95.88 - $117.08 $26,558 - $32,431	277 Added 11.25%	2,740 $306,000
Q3 2021 Nov 04, 2021	BUY	$84.42 - $106.62 $207,926 - $262,605	2,463 New	2,463 $236,000

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Blueprint Investment Partners LLC with notifications on news.